Advances and challenges of HDAC inhibitors in cancer therapeutics

JJ McClure, X Li, CJ Chou - Advances in cancer research, 2018 - Elsevier
Since the identification and cloning of human histone deacetylases (HDACs) and the rapid
approval of vorinostat (Zolinza®) for the treatment of cutaneous T-cell lymphoma, the field of …

Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management

V Ramappa, GP Aithal - Journal of clinical and experimental hepatology, 2013 - Elsevier
Development of idiosyncratic hepatotoxicity is an intricate process involving both concurrent
as well as sequential events determining the direction of the pathways, degree of liver injury …

EASL clinical practice guidelines: drug-induced liver injury

RJ Andrade, GP Aithal, ES Björnsson, N Kaplowitz… - Journal of …, 2019 - Elsevier
Idiosyncratic (unpredictable) drug-induced liver injury is one of the most challenging liver
disorders faced by hepatologists, because of the myriad of drugs used in clinical practice …

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

RJ Fontana, I Liou, A Reuben, A Suzuki, MI Fiel… - Hepatology, 2023 - journals.lww.com
There are currently more than 1000 prescription medications available for use in the United
States and more than 100,000 over-the-counter herbal and dietary supplements (HDS) …

Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines

H Devarbhavi, G Aithal, S Treeprasertsuk… - Hepatology …, 2021 - Springer
Idiosyncratic drug-induced liver injury mimics acute and chronic liver disease. It is under
recognized and underrecognised because of the lack of pathognomonic diagnostic …

[HTML][HTML] Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

C Stephens, M Robles-Diaz, I Medina-Caliz… - Journal of …, 2021 - Elsevier
Background & Aims Prospective drug-induced liver injury (DILI) registries are important
sources of information on idiosyncratic DILI. We aimed to present a comprehensive analysis …

Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice

M Villanueva-Paz, L Morán, N López-Alcántara… - Antioxidants, 2021 - mdpi.com
Idiosyncratic drug-induced liver injury (DILI) is a type of hepatic injury caused by an
uncommon drug adverse reaction that can develop to conditions spanning from …

An official ATS statement: hepatotoxicity of antituberculosis therapy

JJ Saukkonen, DL Cohn, RM Jasmer… - American journal of …, 2006 - atsjournals.org
Drug-induced liver injury (DILI) is a problem of increasing significance, but has been a long-
standing concern in the treatment of tuberculosis (TB) infection. The liver has a central role …

Evidence-based clinical guidelines for immigrants and refugees

K Pottie, C Greenaway, J Feightner, V Welch… - Cmaj, 2011 - Can Med Assoc
Health: Deborah Assayag, Elizabeth Barnett, Jennifer Blake, Beverly Brockest, Giovani
Burgos, Glenn Campbell, Andrea Chambers, Angie Chan, Maryann Cheetham, Walter …

Antituberculosis drug‐induced hepatotoxicity: concise up‐to‐date review

A Tostmann, MJ Boeree, RE Aarnoutse… - Journal of …, 2008 - Wiley Online Library
The cornerstone of tuberculosis management is a 6‐month course of isoniazid, rifampicin,
pyrazinamide and ethambutol. Compliance is crucial for curing tuberculosis. Adverse effects …